| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |